ABBV vs MSFT — AbbVie Inc. vs Microsoft Corporation Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
QuantSoar AI Verdict
ABBV is the better value pick
ABBV: $264.58 · Margin of Safety -30.0%|MSFT: $503.64 · Margin of Safety -31.0%
Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
Loading performance data...
Fundamentals & Valuation Deep Dive
Side-by-side financial metrics and valuation models.
ABBVMetricMSFT
$264.58Current Price$503.64
86.78Fair Value202.75
-67.2%Margin of Safety-59.7%
74.5P/E Ratio28.0
7.3P/S Ratio11.3
78.8P/B Ratio8.5
0.28Beta1.11
$467.5BMarket Cap$3739.8B
0.03%Dividend Yield0.01%
9.8%Profit Margin40.3%
40.0%Operating Margin45.1%
—ROE34.0%
$61.2BRevenue$331.8B
16.3Forward P/E21.3
0.0Debt / Equity29.1
$278.56Analyst Target$577.26
financialProfile
AbbVie Inc.
Current Price$264.58
Fair Value$86.78
Margin of Safety-67.2%
P/E Ratio74.5
P/S Ratio7.3
P/B Ratio-78.8
Beta0.3
Dividend Yield0.03%
Profit Margin9.8%
Operating Margin40.0%
ROE—
Revenue$61.2B
Forward P/E16.3
Debt / Equity—
Analyst Target$278.56
Market Cap$467.5B
financialProfile
Microsoft Corporation
Current Price$503.64
Fair Value$202.75
Margin of Safety-59.7%
P/E Ratio28.0
P/S Ratio11.3
P/B Ratio8.5
Beta1.1
Dividend Yield0.01%
Profit Margin40.3%
Operating Margin45.1%
ROE34.0%
Revenue$331.8B
Forward P/E21.3
Debt / Equity29.1
Analyst Target$577.26
Market Cap$3739.8B
Smart Investment Matcher
Input your budget and horizon. We simulate DCA backtests and recommend the best fit.
Loading smart matcher...
Final Verdict & Actionable Takeaways
Our quantitative verdict
ABBV offers better risk-adjusted value
Based on margin of safety (ABBV wins) and beta safety (ABBV wins).
Related Stock Comparisons
Explore other popular side-by-side matchups and sector peers.